The Carondelet Medical Group in Tucson,Arizona that is participating in innovation model of care,Million Hearts:Cardiovascuar Disease Risk Reduction Model?What is its purpose?

This is a randomized controlled trial that seeks to bridge a gap in cardiovascular care by providing targeted incentives for health care practitioners to engage in beneficiary cardiovascular disease (CVD) risk calculation and population-level risk management. Instead of focusing on the individual components of risk, participating organizations will engage in risk stratification across a beneficiary panel to identify those at highest risk for atherosclerotic cardiovascular disease (ASCVD). The CVD Risk Reduction Model supports both the Million Hearts' goal to prevent one million heart attacks and strokes and the objective of the Centers for Medicare and Medicaid Services (CMS) which is to identify and spread better models of care delivery and payment. This model aims to improve quality while maintaining budget neutrality for Medicare beneficiaries ages 40-79 who have not had a previous heart attack or stroke.